Quantcast

As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation

August 19, 2014

NEW YORK, Aug. 19, 2014 /PRNewswire/ — As power morcellator lawsuits continue to mount in courts around the country, Bernstein Liebhard LLP notes that women in need of fibroid removal or hysterectomy can choose between a number of options that do not involve the use of this potentially dangerous surgical instrument. According to a report published by The Wall Street Journal on August 18(th), these options include a mini-laparotomy and vaginal hysterectomy. Non-surgical options for shrinking uterine fibroids include medications, ultrasound and uterine artery embolization, a procedure that cuts off the blood supply to the fibroids.

http://photos.prnewswire.com/prnvar/20120202/MM47134LOGO

“In light of the safety concerns surrounding uterine morcellation, it is more important than ever before to ensure that patients are aware of all available options for treating fibroids or performing a hysterectomy,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free morcellator lawsuit reviews to women who may have experienced the spread of undiagnosed uterine sarcoma and other cancers due to power morcellation.

Uterine Morcellation and Cancer

Power morcellators are used during laparoscopic hysterectomies and fibroid removals to shred tissue in order to facilitate its removal through a small abdominal incision. On April 17th, the U.S. Food & Drug Administration (FDA) warned that power morcellators have the potential to spread undetected uterine cancer cells into a woman’s peritoneal cavity, upstaging the cancer and greatly reducing the patient’s chances for long-term survival. According to the agency, roughly 1 in 350 women with fibroids actually have undiagnosed uterine sarcoma.

On July 22nd, the Journal of the American Medical Association published a study that appeared to confirm this risk in both older women, as well as those under the age of 50. Days later, Johnson & Johnson’s Ethicon Inc. unit announced a power morcellator recall for three devices marketed by the company, stating that the risks and benefits associated with uterine morcellation were uncertain. Highmark, Inc., one of the nation’s largest Blue Cross/Blue Shield insurance providers has also announced it would end coverage of these procedures, while a number of hospitals have decided to ban or strictly limit the use of power morcellators in uterine surgeries.

Alleged victims of uterine sarcomas and other cancers spread via a power morcellator may be eligible to file a morcellator lawsuit against the manufacturer of the device used in their surgery. To learn more about the risks potentially associated with uterine morcellation, please visit Bernstein Liebhard LLP’s website. Free case reviews can also be obtained by calling (888) 340-4807.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(888) 340-4807

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (888) 340-4807. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
www.injurybeacon.com
https://plus.google.com/115936073311125306742?rel=author

Logo – http://photos.prnewswire.com/prnh/20120202/MM47134LOGO

SOURCE Bernstein Liebhard LLP


Source: PR Newswire



comments powered by Disqus